Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

17.19
Delayed Data
As of Jul 31
 +0.80 / +4.88%
Today’s Change
3.92
Today|||52-Week Range
17.42
+106.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues21.4M18.4M363.0K1.2M
 
 
 
 
 
Depreciation And Amortization1.6M1.7M1.7M1.5M
 
 
 
 
 
 
Operating ExpensesGross Income19.8M------
 
 
General Expenses70.7M69.0M60.3M68.3M
 
 
 
 
 
Research And Development50.9M50.3M41.9M47.6M
 
 
 
 
 
Total Operating Expenses72.3M70.7M62.1M69.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-50.9M-52.3M-61.7M-68.7M
 
 
 
 
 
Extraordinary Credit2.8M653.0K908.0K63.0K
 
 
 
 
 
Extraordinary Charge---600.0K-2.5M-100.0K
 
 
 
 
Interest Expense On Debt148.0K89.0K46.0K1.5M
 
 
 
 
 
Other Expenses70.0K21.0K0.00-77.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-48.0M-52.0M-63.1M-70.0M
 
 
 
 
 
Income Taxes-3.6M-3.2M-3.5M-1.1M
 
 
 
 
 
Net Income-44.4M-48.8M-59.6M-68.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.6M45.6M51.3M74.4M
 
 
 
 
 
Shares To Calculate EPS Diluted34.6M45.6M51.3M74.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.28-$1.07-$1.16-$0.93
 
 
 
 
 
EPS Diluted-$1.28-$1.07-$1.16-$0.93